[1]
|
[1]WORLD HEALTH ORGANIZATION.Golbal tuberculosis report 2015[R/OL].[2015-11-16].World Orangization,2015.http://www.who.int/tb/publications/global_report/en/.
|
[2]
|
[2]FRIEDEN T R,STERLING T R,MUNSIFF S S,et al.Tuberculosis[J].Lancet,2003,362(9387):887-899.
|
[3]
|
[3]DIEL R,LODDENKEMPER R,NIENHAUS A.Evidence-Based Comparison of Commercial Interferon-gamma Release Assays for Detecting Active TB[J].Chest,2009,137(4):952-68.
|
[4]
|
[4]COKER R.Ending Neglect:The elimination of tuberculosis in the united states[J].Jama the Journal of the American Medical Association,2001,286(2):232-233.
|
[5]
|
[5]JIANG B,DING H,LI Z,et al.Evaluation of interferon-gamma release assay(T-SPOT.TBTM)for diagnosis of tuberculosis infection in rheumatic disease patients[J].International Journal of Rheumatic Diseases,2016,19(1):38-42.
|
[6]
|
[6]WORLD HEALTH ORGANIZATION.Guidelines on the management of latent tuberculosis infection[R/OL].[2015-11-16].World Health Organization,2015.http://www.who.int/tb/publications/ltbi_document_page.
|
[7]马锡慧,肖漓,石炳毅.流式微珠阵列术在医学中的研究进展[J].生物技术通讯,2016,27(1):138-141.
|
[8]
|
[8]JOHNSON J L,SSEKASANVU E,OKWERA A,et al.Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis[J].American Journal of Respiratory&Critical Care Medicine,2003,168(2):185-191.
|
[9]
|
[9]BERMUDEZ L E,YOUNG L S.Tumor necrosis factor,alone or in combination with IL-2,but not IFN-gamma,is associated with macrophage killing of Mycobacterium avium complex.[J].Journal of Immunology,1988,140(9):3006-3013.
|
[10]
|
[10]BERMUDEZ L E,STEVENS P,KOLONOSKI P,et al.Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2and tumor necrosis factor.[J].Journal of Immunology,1989,143(9):2996-3000.
|
[11]
|
[11]JEEVAN A,ASHERSON G L.Recombinant interleukin-2limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice.[J].Infection&Immunity,1988,56(3):660-664.
|
[12]
|
[12]VERBON A,JUFFERMANS N P,DEVENTER V,et al.Serum concentrations of cytokines in patients with active tuberculosis(TB)and after treatment[J].Clinical&Experimental Immunology,1999,115(1):110-113.
|
[13]
|
[13]REDFORD P S,MURRAY P J,O'GARRA A.The role of IL-10 in immune regulation during M.tuberculosis infection.[J].Mucosal Immunology,2011,4(3):261-270.
|
[14]
|
[14]CYKTOR J C,CARRUTHERS B,KOMINSKY R A,et al.IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection.[J].Journal of Immunology,2013,190(6):2778-2790.
|
[15]
|
[15]FORTSCH D,ROLLINGHOFF M,STENGER S,et al.IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis.[J].Journal of Immunology,2000,165(2):978-987.
|
[16]
|
[16]HUR YG,GORAK-STOLINSKA P,BEN-SMITH A,et al.Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.[J].Plos One,2013,8(11):e79742-e79742.
|
[17]冯经华,尹凤鸣,严振球.目前结核分枝杆菌感染中重要免疫细胞和细胞因子作用的研究进展[J].临床军医杂志,2007,35(2):291-295.
|
[18]
|
[18] JINFANG Z,PAUL W E.CD4 T cells:Fates,functions,and faults[J].Blood,2008,112(5):1557-1569.
|